Literature DB >> 12029440

Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells.

A M Otto1, C S G Müller, T Huff, E Hannappel.   

Abstract

PURPOSE: Elevated expression of the beta-thymosin isotypes T beta(4), T beta(10), and T(15) appears to be involved in the manifestation of a malignant phenotype of human tumor cells, including those of mammary carcinomas. This has evoked an interest in these peptides as diagnostic/prognostic tumor markers. If increased levels of beta-thymosins correspond to tumor malignancy, the question arises whether tumor growth inhibition induced by chemotherapeutic drugs would reduce their expression.
METHODS: Two human breast cancer cell lines, the estrogen receptor(ER)-positive MCF-7 and the ER-negative MDA-MB231, were thus analyzed for the amount of beta-thymosin mRNAs by RNase protection assay and for the respective peptide levels by HPLC following different hormonal and drug treatments.
RESULTS: Both cell lines, growing in medium with 10% FCS, contain T beta(4) (400-500 fg/cell) and Tbeta(10) (about 100 fg/cell), but no T beta(15). Incubating MCF-7 cells with tamoxifen (1 microM) for 5 days resulted in about 80% growth inhibition and in reduction of intracellular T beta(4) and T beta(10) concentrations by about 40%. Levels of T beta(4) and T beta(10)-mRNA were reduced by about 60%. In contrast, cisplatin (2 microM) changed neither the peptide concentrations nor the mRNA levels of beta-thymosins, in spite of marked growth inhibition. In addition, no changes in beta-thymosin expression were observed in MDA-MB231 cells treated with either drug. MCF-7 cells maintained in estrogen-poor medium (10% horse serum) or stimulated to grow with estradiol (1 nM) had Tbeta(4) and T beta(10) concentrations reduced by about 30%, but changes in T beta(4)- and T beta(10)-mRNA levels did not correspond to those of the peptide.
CONCLUSION: Expression of T beta(4) and T beta(10) mRNAs and their peptides is differentially regulated and does not correlate with growth. Instead, reduced beta-thymosin expression may be linked to more intensive TRITC-phalloidin staining of F-actin lining the membrane at sites of intimate cell-cell contacts, while increased beta-thymosin levels appear in cells with more extensive substrate adhesion. This suggests that beta-thymosins play a role in cell surface dynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029440     DOI: 10.1007/s00432-002-0332-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  10 in total

1.  Phylogenetic analysis and developmental expression of thymosin-beta4 gene in amphioxus.

Authors:  Xiangwei Huang; Wei Zhang; Hongwei Zhang
Journal:  Dev Genes Evol       Date:  2005-03-24       Impact factor: 0.900

2.  Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility.

Authors:  Aase Elisabeth Maelan; Trine Kring Rasmussen; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

3.  In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA.

Authors:  T-C Chao; L-C Chan; S-Y Ju; M-C Tang; C-Y Liu; P-M Chen; C-H Tzeng; Y Su
Journal:  Cancer Gene Ther       Date:  2014-08-15       Impact factor: 5.987

4.  Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.

Authors:  Nam Soo Kim; Yun-Jeong Kang; Jin-Ok Jo; Heung Yeol Kim; Young Rim Oh; Young-Ok Kim; Min Hyung Jung; Mee Sun Ock; Hee-Jae Cha
Journal:  Pathol Oncol Res       Date:  2011-01-07       Impact factor: 3.201

5.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.

Authors:  Robert Klopfleisch; Dido Lenze; Michael Hummel; Achim D Gruber
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

6.  Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.

Authors:  Jochen F Peter; Angela M Otto; Bernhard Wolf
Journal:  J Biomol Tech       Date:  2007-12

7.  Cisplatin exposure damages resident stem cells of the mammalian inner ear.

Authors:  Eric L Slattery; Kazuo Oshima; Stefan Heller; Mark E Warchol
Journal:  Dev Dyn       Date:  2014-06-25       Impact factor: 3.780

8.  Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract.

Authors:  S Nemolato; T Cabras; M U Fanari; F Cau; D Fanni; C Gerosa; B Manconi; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2010-10-13       Impact factor: 3.188

9.  Conversion of Hyperpolarized [1-13C]Pyruvate in Breast Cancer Cells Depends on Their Malignancy, Metabolic Program and Nutrient Microenvironment.

Authors:  Martin Grashei; Philipp Biechl; Franz Schilling; Angela M Otto
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

10.  Structural Similarity with Cholesterol Reveals Crucial Insights into Mechanisms Sustaining the Immunomodulatory Activity of the Mycotoxin Alternariol.

Authors:  Giorgia Del Favero; Raphaela M Mayer; Luca Dellafiora; Lukas Janker; Laura Niederstaetter; Chiara Dall'Asta; Christopher Gerner; Doris Marko
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.